An experimental COVID-19 vaccine from Novavax appears to offer strong protection in late-stage UK, South Africa studies

January 28, 2021

WASHINGTON (AP) — An experimental COVID-19 vaccine from Novavax appears to offer strong protection in late-stage UK, South Africa studies.